CCR2 (Gene)

Organism:

Homo sapiens

Synonyms:C-C motif chemokine receptor 2, CC-CKR-2, CCR-2, CCR2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, ENTREZ:729230, HGNC:1603, MCP-1-R, MIM:601267, NM_001123041, NM_001123396, NP_001116513, NP_001116868, XM_011534069, XP_011532371

Omim:OMIM:601267

Id:61756661-c08a-5d54-967f-ebcb1a980a42

Hgnc:HGNC:1603

Entrez:729230

Ensembl:ENSG00000121807

Description:C-C motif chemokine receptor 2

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CCR2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CCR2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CCR2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CCR2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CCR2.

Results found

Linked to

	Label	Description
	GSE176008 pyridoxine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE147662 3 V 5 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE191005 ENL knockout MOLM-13 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158969 1 V 0 TRASTUZUMAB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 etoposide leukocyte 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199204,GSE211619 4 V 0 GLUTAMINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 0 V 1 AZACITIDINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE103510 STAT5 inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE176008 pyridoxine 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE147662 3 V 5 NICOTINAMIDE MOUSE UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE191005 ENL knockout MOLM-13 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 3 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE158969 1 V 0 TRASTUZUMAB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE120612 etoposide leukocyte 4 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE199204,GSE211619 4 V 0 GLUTAMINE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE176008 0 V 1 AZACITIDINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 6 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE103510 STAT5 inhibition 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.